cyproterone acetate has been researched along with Multiple Primary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Orhan, D; Ozdiler, E; Sak, SD; Tulunay, O; Yaman, O | 1 |
| Bonini, R; Papineschi, F; Pistolisi, D; Spremolla, G | 1 |
2 other study(ies) available for cyproterone acetate and Multiple Primary Neoplasms
| Article | Year |
|---|---|
Carcinosarcoma of the prostate. A case report and a possible evidence on the role of hormonal therapy.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Antineoplastic Agents; Carcinosarcoma; Cyproterone Acetate; Humans; Immunohistochemistry; Male; Neoplasms, Multiple Primary; Prostatectomy; Prostatic Neoplasms; Receptors, Progesterone | 1997 |
[Chronic myeloid leukemia and carcinoma of the prostate].
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Busulfan; Cyproterone; Cyproterone Acetate; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Neoplasms, Multiple Primary; Prostatic Neoplasms; Remission Induction | 1989 |